Teresa
Lozano Moreda
Profesional Investigadora
![Foto de Teresa](/img/nophoto.png)
![Foto de NavarraBiomed](/img/noimage_org.png)
NavarraBiomed
Pamplona, EspañaPublications in collaboration with researchers from NavarraBiomed (2)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1